Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.
Navigating advanced medical treatments in another country can feel complex. For those exploring options like NK cell therapy, understanding the process from start to finish is a crucial first step. This guide provides a clear, step-by-step overview for international patients considering NK cell therapy at Grand Green Osaka Umekita Clinic, helping you understand what to expect on your journey to care in Japan.
The Patient Journey: From First Contact to Treatment
The process is designed to be as clear and supportive as possible for patients traveling from abroad. While every individual’s case is unique and requires a physician’s assessment, the general pathway follows several key stages.
- Step 1: Initial Inquiry and Information Gathering
Your journey begins when you contact us. You can reach out with your questions and provide initial information about your medical condition. We will provide general information about the therapy and the process. - Step 2: Medical Information Review & Remote Consultation
Before a formal consultation, our medical team will need to review your existing medical records. This helps us understand your health status and medical history. Following this review, we can arrange a remote consultation with a physician to discuss your situation in more detail and explore if you might be a suitable candidate for this therapy. - Step 3: Treatment Plan Proposal
If the physician determines that NK cell therapy could be a viable option for you, a personalized treatment plan will be proposed. This will outline the suggested frequency of infusions and the overall timeline. This is an opportunity to ask detailed questions before making any decisions. - Step 4: Travel and Arrival in Osaka
Once you decide to proceed, you will make arrangements to travel to Osaka, Japan. Our clinic is conveniently located in the Umeda area. We recommend planning your travel to allow for sufficient time for your appointments without feeling rushed. - Step 5: In-Person Consultation and Blood Draw
Your first appointment at Grand Green Osaka Umekita Clinic will include an in-person consultation with the doctor. This is to confirm the treatment plan and answer any final questions. If you proceed, a standard blood draw will be performed to collect the cells needed for the therapy. - Step 6: Cell Processing
Your collected blood sample is sent to a specialized, licensed cell processing facility. Here, your natural killer (NK) cells are isolated, activated, and expanded in number over a period of time under strict quality and safety controls. - Step 7: NK Cell Infusion
Once your cultured cells are ready, you will return to the clinic. The expanded and activated NK cells are returned to your body through a simple intravenous (IV) infusion. The procedure itself is typically brief and does not require hospitalization. - Step 8: Follow-up
After the infusion, your physician will discuss the next steps, including any subsequent treatments as per your plan and recommendations for follow-up care.
Understanding NK Cell Therapy
NK (Natural Killer) cells are a vital part of your body’s innate immune system. They are specialized lymphocytes that can identify and attack abnormal cells, such as cancer cells or virus-infected cells, without prior sensitization. However, factors like age, stress, or illness can sometimes weaken NK cell activity.
NK cell therapy is a form of immunotherapy that aims to support this natural defense mechanism. By culturing a patient’s own (autologous) cells outside the body to increase their number and activity, the therapy seeks to reinforce the body’s immune surveillance. Because it uses your own cells, serious side effects have rarely been reported. However, as with any medical procedure, potential risks exist, and temporary symptoms like fever or fatigue may occur. It’s important to understand that this therapy is often used in conjunction with standard treatments like chemotherapy or radiation, not as a replacement for them. The effectiveness and suitability of this therapy depend on individual health conditions and must be evaluated by a doctor.
Key Considerations for International Patients
When considering any medical treatment abroad, it’s essential to be well-informed. Here are some key points regarding NK cell therapy in Japan:
- Regulatory Framework: In Japan, treatments like NK cell therapy are provided under the Act on the Safety of Regenerative Medicine. This means that treatment plans are submitted to and reviewed by the government, and cell processing is conducted at licensed facilities, ensuring a high standard of safety management.
- Physician’s Assessment is Essential: This therapy is not suitable for everyone. A thorough evaluation of your medical condition and history by a qualified physician is required to determine eligibility. The potential benefits and risks must be carefully weighed in your specific case.
- Private Medical Care: NK cell therapy is provided as a non-insured, private medical service. It is not covered by Japanese public health insurance. All costs associated with the treatment are the responsibility of the patient.
Preparing for Your Consultation in Osaka
To make your consultation as productive as possible, we recommend preparing your medical information in advance. This typically includes recent diagnoses, treatment history, imaging reports, and lab results. Having this information ready will help our medical team gain a comprehensive understanding of your health situation. Our clinic is located in the heart of Osaka’s Umeda district, a major international hub, making it accessible for visiting patients.
Learn More About NK Cell Therapy
This article provides a general overview of the process. For more detailed information about the therapy itself, its features, and important considerations such as fees, potential risks, and side effects, we encourage you to review our main treatment page. A thorough understanding is key to making an informed decision in consultation with a physician.
For comprehensive details, please visit our NK Cell Therapy information page.
Summary
Embarking on a medical journey abroad requires careful planning and clear information. At Grand Green Osaka Umekita Clinic, we have a structured process to guide international patients seeking NK cell therapy. The path involves initial reviews, consultations, and a carefully managed treatment cycle. The most important step is a consultation with a doctor to determine if this approach is appropriate for your individual health circumstances. We are here to provide the necessary information to help you explore your options.
- 1Consultation & PlanningRemote and in-person consultation
- 2Blood DrawCollect your cells at our clinic
- 3Cell CultureNK cells are activated and expanded
- 4NK Cell InfusionReturn cultured cells to your body
- 5Follow-upDiscuss next steps with your doctor
This is a simplified diagram to illustrate the process
References
- PubMed: Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation. (2024)
- PubMed: Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: updated recommendations by the EBMT/ELN International Working Group. (2024)
- PubMed: International Delphi Consensus on the Management of AQP4-IgG+ NMOSD: Recommendations for Eculizumab, Inebilizumab, and Satralizumab. (2023)
- PubMed: 36th International Symposium on Intensive Care and Emergency Medicine : Brussels, Belgium. 15-18 March 2016. (2016)
- PubMed: Adult-onset Still's disease. (2014)
- PMC: Dual Regulation of Post-Translational Modification of Proteins: Bottlenecks and Breakthroughs in NK Cell Therapy for Glioblastoma. (2026)
- PMC: Potential therapeutic roles of natural killer cells in acute myeloid leukemia: a systematic review study. (2025)
- PMC: A clinically relevant large-scale biomanufacturing workflow to produce natural killer cells and natural killer cell-derived extracellular vesicles for cancer immunotherapy. (2023)
- MHLW (Japan): Regenerative Medicine — Ministry of Health, Labour and Welfare, Japan
Supervising Physician
Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic
Hidenori Shimada
Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.
* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.